How a new Alzheimer’s drug trial could one day help someone you know

The clinical trial started in 2023 and will run for four years

How a new Alzheimer's drug trial could one day help someone you know The Cleveland Clinic is conducting a study testing lecanemab in people who are not yet experiencing symptoms. Reporter: Heather Graf (InvestigateTV)

(InvestigateTV) — The Cleveland Clinic for Brain Health in Las Vegas is conducting a clinical trial that’s taking a deeper look into Lecanemab, a drug the neurologist we spoke to says could prevent or delay the symptoms of Alzheimer’s.

Reporter Heather Graf shows us the research now underway, and how it could one day maybe help you or someone you know. Watch the full story in the video at the top of this story.

Lecanemab received accelerated FDA approval in January 2023 and traditional approval in July, for use in patients with early signs of Alzheimer’s and dementia.

Dr. Charles Bernick is heading up a study testing the drug in people who are not experiencing symptoms.

The clinical trial started in 2023 and will run for four years. The participants are over the age of 55, have a family history of Alzheimer’s disease, and have noticed some memory changes in themselves.

[ CLICK HERE TO WATCH THE FULL EPISODE OF InvestigateTV+ INCLUDING THIS STORY ]

Copyright 2023 Gray Media Group, Inc. All rights reserved.

Heather Graf

Heather Graf

Heather Graf is an award-winning journalist for InvestigateTV+, working as a national reporter based in Washington, D.C.

Wade Smith

Wade Smith

Wade leads the production workflow and strategy development of digital content for Gray Television’s National Investigative Team. He started his digital career in Atlanta, GA in 2009 after graduating from the University of Alabama.